Skip to main content
Earnings Labs
NS

Nasus Pharma Ltd. (NSRX)

AMEX·Healthcare·Biotechnology

$3.01

-5.05%

Mkt Cap $27.39M

Analyst Ratings

No recent rating data.

Price Target (1 analysts)

$22.00

Range $22.00$22.00

Implied Upside

+630.9%

Consensus $22.00 vs current $3.01